2023 Form 5500 filing — Sav-More Drug, LLC 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241010163639NAL0010269043001) for Sav-More Drug, LLC 401(K) Plan, reported by Sav-More Drug, LLC under EIN 75-2047264 and plan number 001. It reports 168 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20241010163639NAL0010269043001
Filing year
2023
Form type
2
Plan sponsor
Sav-More Drug, LLC
EIN
75-2047264
Plan number
001
Location
Tyler, TX
Participants
168
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$8,094,889
Net assets (EOY)
$8,094,889
Employer contributions
$164,993
Participant contributions
$357,519
Total income / additions
$1,650,705
Benefits paid
$1,287,021
Administrative expenses
$42,018
Total expenses
$1,329,039
Net increase / (decrease)
$321,666
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Transamerica Retirement SolutionsRECORDKEEPER$42,018$0
Hilltop Securities Inc.BROKER$0$15,446

Related Form 5500 pages